Comparison of Hemodynamic Variables Between Using Conventional Invasive Catheter Monitoring and Non-invasive Piezoelectric Sensor

July 31, 2025 updated by: Jin-Young Hwang, SMG-SNU Boramae Medical Center
Arterial pressure is obtained from invasive arterial monitoring and noninvasive arterial monitoring using piezoelectric sensor and compared.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Cases who require Invasive arterial pressure monitoring d/t bleeding.

Exclusion Criteria:

  • Patients with cardiovascular disease, cerebrovascular diseases, renal disease, or Marfan syndrome
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Invasive group
Arterial pressure is obtained from invasive arterial monitoring
Other: Arterial pressure monitoring
Arterial pressure is monitored and obtained
Experimental: Noninvasive arterial monitoring
Arterial pressure is obtained from non-invasive arterial monitoring
Other: Arterial pressure monitoring
Arterial pressure is monitored and obtained

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Arterial pressure
Time Frame: For 30 min after the induction of anesthesia,
After the induction of anesthesia, 20G catheter is placed for invasive arterial pressure monitoring in the radial artery and pressure sensor is attached for noninvasive arterial pressure monitoring in the contralateral radial artery. Then, invasive and noninvasive arterial pressures are monitored and obtained simultaneously.
For 30 min after the induction of anesthesia,

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

SMG-SNU Boramae Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 22, 2025

Primary Completion (Estimated)

December 18, 2026

Study Completion (Estimated)

December 18, 2026

Study Registration Dates

First Submitted

July 31, 2025

First Submitted That Met QC Criteria

July 31, 2025

First Posted (Actual)

August 7, 2025

Study Record Updates

Last Update Posted (Actual)

August 7, 2025

Last Update Submitted That Met QC Criteria

July 31, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 202459

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Monitoring

Clinical Trials on Arterial pressure monitoring

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe